Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000927016-02-003466
Filing Date
2002-06-28
Accepted
2002-06-28 15:11:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-3 df3.txt F-3 85801
3 AGREEMENT AND PLAN OF MERGER dex21.txt EX-2.1 172377
4 OPINION OF DE BRAUW BLACKSTONE dex51.txt EX-5.1 9002
5 OPINION OF BAKER & MCKENZIE dex81.txt EX-8.1 3017
6 OPINION OF MINTZ,LEVIN dex82.txt EX-8.2 3254
7 PRESS RELEASE dex991.txt EX-99.1 7392
  Complete submission text file 0000927016-02-003466.txt   282838
Mailing Address 28159 AVENUE STANFORD VALENCIA CA 91355
Business Address 5911 KJ VENLO SPOORSTRAAT P7 50 31-77-320-84
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-91474 | Film No.: 02691308
SIC: 2836 Biological Products, (No Diagnostic Substances)